VOYA Investment Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.5M Buy
54,332
+8,742
+19% +$2.04M 0.01% 548
2026
Q1
$10.4M Sell
45,590
-11,485
-20% -$2.57M 0.01% 611
2025
Q4
$12.2M Sell
57,075
-16,130
-22% -$3.33M 0.01% 602
2025
Q3
$14.6M Buy
73,205
+39,880
+120% +$7.44M 0.01% 571
2025
Q2
$5.75M Buy
33,325
+15,670
+89% +$2.55M 0.01% 901
2025
Q1
$2.75M Hold
17,655
– – ﹤0.01% 1174
2024
Q4
$2.43M Hold
17,655
– – ﹤0.01% 1232
2024
Q3
$2.64M Hold
17,655
– – ﹤0.01% 1248
2024
Q2
$2.41M Sell
17,655
-1,925
-10% -$262K ﹤0.01% 1261
2024
Q1
$2.96M Hold
19,580
– – ﹤0.01% 1188
2023
Q4
$2.47M Buy
19,580
+12,165
+164% +$1.21M ﹤0.01% 1291
2023
Q3
$694K Hold
7,415
– – ﹤0.01% 1861
2023
Q2
$662K Sell
7,415
-45,620
-86% -$3.97M ﹤0.01% 1919
2023
Q1
$5.69M Buy
53,035
+28,060
+112% +$3.21M 0.01% 939
2022
Q4
$3.05M Buy
24,975
+9,805
+65% +$1.14M ﹤0.01% 1169
2022
Q3
$1.57M Buy
+15,170
New +$1.44M ﹤0.01% 1427

Other funds holding ASND

VOYA Investment Management's ASND Position: Q2 2026 in Review

VOYA Investment Management increased its Ascendis Pharma A/S (ASND) stake by 19% in Q2 2026, buying an estimated $2.04M and bringing the position to 54,332 shares worth $14.5M. The position accounts for 0.01% of the portfolio, ranked #548.

VOYA Investment Management first reported a position in ASND in Q3 2022 and has held it in 16 quarters since. The position peaked at $14.6M in Q3 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • VOYA Investment Management held 54,332 shares of Ascendis Pharma A/S worth $14.5M as of Q2 2026.
  • VOYA Investment Management bought 8,742 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.04M.
  • Ascendis Pharma A/S made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #548 holding.
  • VOYA Investment Management first reported a position in Ascendis Pharma A/S in Q3 2022 and has held it in 16 quarters since.
  • VOYA Investment Management's Ascendis Pharma A/S position peaked at $14.6M in Q3 2025.
  • 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.